Connect with us

For The First Time In 10 Years Companies Will Sell More Stock Than They Buy Back

For The First Time In 10 Years Companies Will Sell More Stock Than They Buy Back

Tyler Durden

Mon, 12/07/2020 – 20:40

For US corporations, the "teens" decade – the years from 2010 to 2019 – was a historic "get rich quick" boom for..

Published

on

For The First Time In 10 Years Companies Will Sell More Stock Than They Buy Back Tyler Durden Mon, 12/07/2020 - 20:40

For US corporations, the "teens" decade - the years from 2010 to 2019 - was a historic "get rich quick" boom for management when buybacks emerged as the most powerful force levitating stocks (and equity-linked compensation) as companies collectively issued trillions in debt and used the proceeds to repurchase over $10 trillion worth of their own shares, in the process dramatically lifting the stock market and reducing the number of outstanding shares (we called it a slow-motion MBO) and pushing the S&P's earnings per share ever higher even when there was no actual earnings growth simply because the number of shares declined year after year.

All of that changed in 2020 when thanks to covid, central banks made a triumphal return to their core competency of propping up stocks at all costs (just moments ago we reported that the BOJ is now the single-biggest owner of Japanese stocks) and by injecting over $20 trillion in liquidity in 2020, a rate of over $1.2 billion every hour, buybacks were no longer required to push markets higher and preserve the biggest asset bubble ever created. What also changed is that since buybacks were no longer needed, with the Fed and its central bank peers backstopping all risk assets, buybacks reversed and for the first time since 2010, in 2020 companies will sell more stock than they buy back.

As Bloomberg reports, "while American firms normally repurchase way more stock than they sell, this year has been different, as offerings by everyone from Snowflake Inc. to Warner Music Group Corp. flooded the market with shares." It's not just growth stocks that are rushing to capitalize from the market's peak euphoria phase, which according to Goldman has seen positioning so "extremely stretched" it is currently in the 98th percentile in history:

As Bloomberg notes, companies that were hurt most during the pandemic, from airlines to cruise lines, are also rushing to raise cash and shore up balance sheets. And they are finding plenty of willing buyers.

The result is that amid the flood of equity offerings, both initial and secondary, companies have announced plans to raise about $510 billion via share offerings in 2020, up 50% from last year, according to data compiled by EPFR. This means that for the first time since the 2009 crisis, that amount of stock sales matches the amount that companies announced they’d remove via buybacks and takeovers. For context, over the past decade an average of $3 was bought back (thanks to ultra cheap debt) for every $1 raised.

Normally, the reduction in buybacks would be a flashing red alert as the largest source of stock demand was no longer there. However, this is anything but "normal times", as central banks are now injecting such an unprecedented firehose of liquidity into  markets - not the economy - even the BIS is shocked.

It's also the case that normally, such a flood of selling would hit stocks simply due to excess supply. But, yet again, in this bizarro centrally-planned freakshow of a "market" nobody has any idea what will happen as Randy Frederick, VP of trading and derivatives for the Schwab Center for Financial Research, freely admits: "corporate demand is one component that drives the market higher that is no longer relevant in this risk-on atmosphere. On its own, I would not say it makes the market go down, but it might cause the market to flatten out and not go much higher." Or it could just send stocks soaring even more; the reality is that we now live in a centrally-planned world where corporate actions no longer impact prices - those are only influenced by fund flows - and as such the surge in stock offerings could merely accelerate the melt up. Ultimately, it's all what central banks decide.

One thing we do know is that the explosion in offerings is finally increasing the total pool of stocks (another trend that normally pressures stock prices at market tops in the past, but again, this is anything but normal). The S&P 1500 Index divisor, a proxy for outstanding shares, has risen 0.2% this year, its first increase in 10 years according to Bloomberg data.

Yet another warning sign: while the boom in IPOs underscores "a robust market" according to Bloomberg, the increase in share counts could also be viewed as an indication companies are "selling high," with valuations too attractive to resist - while being too rich to justify buybacks (or simply refusing to take a gamble to issue debt and repurchase stock at a time when the airline industry can't get a bailout due to its chronic stock repurchases in the past decade). To be sure, at 22 times earnings, the S&P 500 trades near the highest multiple since the dot-com era.

"Obviously when the market is at an all-time high, you want to issue shares now, because the shares are worth a lot more than they would be if the market was tanking," EPFR analyst Winston Chua told Bloomberg. "Looking at the market broadly, companies are not being supportive of share prices."

Luckily, markets no longer exist as they have been completely replaces as policy tools for activist central planners armed with money printers. It's also why skeptics who rely on logic and fundmentals are proven wrong again and again: "There’s a lack of an incremental buyer out there, so that’s a negative, and it still signals some caution as companies let the cash accumulate," said Mike Bailey, director of research at FBB Capital Partners. Which is true, but one just has to spin the data ever so slightly to represent it in a bullish light, as Bailey does next: "The flip side is, you are building more pressure for companies to really drop the hammer and start to buy back stock next year and into 2022."

That’s the scenario envisioned by Goldman chied strategist David Kostin: In 2021, he expects net share repurchases will double to $300 billion and equity issuance will fall from this year’s record high, his team forecast. After all, he has to use fundamentals to justify his 4,300 price target - saying "buy because central banks got your back" would be frowned upon.

Of course, for the skeptics out there who are screaming this is idiocy pure and simple, you are right... at least based on empirical data. As Bloomberg notes, Corporate actions on equities showed a close inverse relationship with the market’s performance. During the two decades through 2015, companies boosted net equity demand in 15 different years, 12 of which saw the S&P 500 gain, a study by EPFR showed. In the five years when corporate supply increased, the equity benchmark fell 60% of the time.

But - once again - this is anything but normal times: we now live in a world where central banks have just one purpose: to keep stocks rising even higher because the moment the game of musical chairs stops, it's all over.

That said, there is a silver lining: companies are once again very cash rich. The new listings on U.S. exchanges have raised more than $150 billion this year. Even firms recently left for dead such as Airbnb - it rents out apartments during the worst pandemic the world has seen in a century - just filed to sell as much as $2.6 billion to cap one of the busiest years ever. Other companies planning listings include food delivery service DoorDash and video-game company Roblox.

"In every cycle, when we say, ‘OK, that was the deal the market rolled over on,’ and all of a sudden everyone’s pulled in their horns," said Arthur Hogan, chief market strategist at National Securities Corp. “I don’t think we’re there yet, but certainly the number of deals has been pretty historic,” he added. "Companies that shouldn’t be coming out come out and there’s always a tipping point."

Yes Art, but thanks to Jerome Powell and his central-planning friends, "this time continues to be different."

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending